Cancer Detection based on Microarray Data Classification Using FLNN and Hybrid Feature Selection

Author:

Ghozy Ghulamul Afif ,Adiwijaya ,Widi Astuti

Abstract

Cancer is one of the second deadliest diseases in the world after heart disease. Citing from the WHO's report on cancer, in 2018 there were around 18.1 million cases of cancer in the world with a total of 9.6 million deaths. Now that bioinformatics technology is growing and based on WHO’s report on cancer, an early detection is needed where bioinformatics technology can be used to diagnose cancer and to help to reduce the number of deaths from cancer by immediately treating the person. Microarray DNA data as one of the bioinformatics technology is becoming popular for use in the analysis and diagnosis of cancer in the medical world. Microarray DNA data has a very large number of genes, so a dimensional reduction method is needed to reduce the use of features for the classification process by selecting the most influential features. After the most influential features are selected, these features are going to be used for the classification and predict whether a person has cancer or not. In this research, hybridization is carried out by combining Information Gain as a filtering method and Genetic Algorithm as a wrapping method to reduce dimensions, and lastly FLNN as a classification method. The test results get colon cancer data to get the highest accuracy value of 90.26%, breast cancer by 85.63%, lung cancer and ovarian cancer by 100%, and prostate cancer by 94.10%.

Publisher

Ikatan Ahli Informatika Indonesia (IAII)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3